ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Anti-NCR2 Antibody [B-N44] - BSA and Azide free (A342082)

Mouse monoclonal [B-N44] IVD antibody to NCR2 for Flow Cytometry.

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 10-14 business days.
Name
Anti-NCR2 Antibody [B-N44] - BSA and Azide free
Description
Mouse monoclonal [B-N44] IVD antibody to NCR2.
Specificity
This product recognizesnatural and recombinant NKp44.
Applications
Flow Cytometry
Reactivity
Human
Immunogen
Recombinant human NKp44-FC.
Host
Mouse
Clonality
Monoclonal
Clone ID
B-N44
Myeloma
Source: Myeloma X63/AG.8653 x Balb/c node cells
Isotype
Mouse IgG1 Kappa light chain
Conjugate

Unconjugated

Concentration
1.0 mg/mL (+/- 10 %)
Product Form
Liquid
Formulation
Phosphate-buffered saline. Sterile-filtered through 0.22µm. Carrier and preservative free.
Storage
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze/thaw cycles.
General Notes
For bulk or custom IVD raw material requests, contact us directly.

IVD reagents are supplied in accordance with standard industry lead times of 4-6 weeks. Where products are in stock, dispatch typically occurs within 7-10 business days.
Synonyms
CD336, LY95, Lymphocyte antigen 95 homolog, Natural cytotoxicity triggering receptor 2, Natural killer cell p44-related protein, NK cell-activating receptor, NK-p44, NKp44
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Anti-NCR2 Antibody [B-N44] - BSA and Azide free (A342082)? Please let us know so that we can list the citation on this page.

Alternative products to Anti-NCR2 Antibody [B-N44] - BSA and Azide free (A342082)

Proteins predicted to interact with NCR2

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
99.9% Relevancy Score
99.5% Relevancy Score
99.5% Relevancy Score
98.4% Relevancy Score
97.1% Relevancy Score
96.3% Relevancy Score
95.3% Relevancy Score
93.5% Relevancy Score
93.2% Relevancy Score